purchase customization

1 Study Coverage
1.1 Anti-Obesity Drugs (Anti-obesity Medication) Product Introduction
1.2 Market by Type
1.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prescription Drugs
1.2.3 OTC Drugs
1.3 Market by Application
1.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Childhood (0-6)
1.3.3 Juvenile (7-17)
1.3.4 Youth (18-40)
1.3.5 Middle Aged (41-60)
1.3.6 Elderly (Above 60)
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Estimates and Forecasts 2017-2028
2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Estimates and Forecasts 2017-2028
2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region
2.4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2022)
2.4.2 Global Sales Anti-Obesity Drugs (Anti-obesity Medication) by Region (2023-2028)
2.5 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region
2.5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2022)
2.5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Manufacturers
3.1.1 Global Top Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers by Sales (2017-2022)
3.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-Obesity Drugs (Anti-obesity Medication) in 2021
3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers
3.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Manufacturers (2017-2022)
3.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anti-Obesity Drugs (Anti-obesity Medication) Revenue in 2021
3.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type
4.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Sales by Type (2017-2022)
4.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Sales by Type (2023-2028)
4.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Type (2017-2028)
4.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type
4.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Revenue by Type (2017-2022)
4.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Type (2017-2028)
4.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type
4.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Type (2017-2022)
4.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application
5.1.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Sales by Application (2017-2022)
5.1.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Sales by Application (2023-2028)
5.1.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Sales Market Share by Application (2017-2028)
5.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application
5.2.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Historical Revenue by Application (2017-2022)
5.2.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Revenue Market Share by Application (2017-2028)
5.3 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application
5.3.1 Global Anti-Obesity Drugs (Anti-obesity Medication) Price by Application (2017-2022)
5.3.2 Global Anti-Obesity Drugs (Anti-obesity Medication) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
6.1.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
6.1.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
6.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
6.2.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
6.2.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
6.3 North America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
6.3.1 North America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
6.3.2 North America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
7.1.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
7.1.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
7.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
7.2.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
7.2.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
7.3 Europe Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
7.3.1 Europe Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
7.3.2 Europe Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
8.1.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
8.1.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
8.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
8.2.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
8.2.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
8.3 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Region
8.3.1 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Sales by Region (2017-2028)
8.3.2 Asia Pacific Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
9.1.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
9.1.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
9.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
9.2.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
9.2.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
9.3 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
9.3.1 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
9.3.2 Latin America Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Type
10.1.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Type (2017-2028)
10.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Application
10.2.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Application (2017-2028)
10.3 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Market Size by Country
10.3.1 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anti-Obesity Drugs (Anti-obesity Medication) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Zafgan
11.1.1 Zafgan Corporation Information
11.1.2 Zafgan Overview
11.1.3 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Zafgan Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zafgan Recent Developments
11.2 Vivus
11.2.1 Vivus Corporation Information
11.2.2 Vivus Overview
11.2.3 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Vivus Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vivus Recent Developments
11.3 Shionogi
11.3.1 Shionogi Corporation Information
11.3.2 Shionogi Overview
11.3.3 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shionogi Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shionogi Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Rhythm Pharmaceuticals
11.5.1 Rhythm Pharmaceuticals Corporation Information
11.5.2 Rhythm Pharmaceuticals Overview
11.5.3 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rhythm Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rhythm Pharmaceuticals Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Orexigen Therapeutics
11.7.1 Orexigen Therapeutics Corporation Information
11.7.2 Orexigen Therapeutics Overview
11.7.3 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Orexigen Therapeutics Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Orexigen Therapeutics Recent Developments
11.8 Novo Nordisk
11.8.1 Novo Nordisk Corporation Information
11.8.2 Novo Nordisk Overview
11.8.3 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novo Nordisk Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novo Nordisk Recent Developments
11.9 Norgine
11.9.1 Norgine Corporation Information
11.9.2 Norgine Overview
11.9.3 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Norgine Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Norgine Recent Developments
11.10 Nalpropion Pharmaceuticals Inc.
11.10.1 Nalpropion Pharmaceuticals Inc. Corporation Information
11.10.2 Nalpropion Pharmaceuticals Inc. Overview
11.10.3 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Nalpropion Pharmaceuticals Inc. Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nalpropion Pharmaceuticals Inc. Recent Developments
11.11 Merck
11.11.1 Merck Corporation Information
11.11.2 Merck Overview
11.11.3 Merck Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Merck Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Merck Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Corporation Information
11.12.2 GlaxoSmithKline Overview
11.12.3 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 GlaxoSmithKline Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GlaxoSmithKline Recent Developments
11.13 F.Hoffmann-La Roche
11.13.1 F.Hoffmann-La Roche Corporation Information
11.13.2 F.Hoffmann-La Roche Overview
11.13.3 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 F.Hoffmann-La Roche Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 F.Hoffmann-La Roche Recent Developments
11.14 Eisai
11.14.1 Eisai Corporation Information
11.14.2 Eisai Overview
11.14.3 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Eisai Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Eisai Recent Developments
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Corporation Information
11.15.2 Boehringer Ingelheim Overview
11.15.3 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Boehringer Ingelheim Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Boehringer Ingelheim Recent Developments
11.16 Bayer AG
11.16.1 Bayer AG Corporation Information
11.16.2 Bayer AG Overview
11.16.3 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Bayer AG Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Bayer AG Recent Developments
11.17 AstraZeneca
11.17.1 AstraZeneca Corporation Information
11.17.2 AstraZeneca Overview
11.17.3 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 AstraZeneca Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 AstraZeneca Recent Developments
11.18 Arena Pharmaceuticals
11.18.1 Arena Pharmaceuticals Corporation Information
11.18.2 Arena Pharmaceuticals Overview
11.18.3 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Arena Pharmaceuticals Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Arena Pharmaceuticals Recent Developments
11.19 Amylin
11.19.1 Amylin Corporation Information
11.19.2 Amylin Overview
11.19.3 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Amylin Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Amylin Recent Developments
11.20 Alizyme
11.20.1 Alizyme Corporation Information
11.20.2 Alizyme Overview
11.20.3 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Alizyme Anti-Obesity Drugs (Anti-obesity Medication) Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Alizyme Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Chain Analysis
12.2 Anti-Obesity Drugs (Anti-obesity Medication) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-Obesity Drugs (Anti-obesity Medication) Production Mode & Process
12.4 Anti-Obesity Drugs (Anti-obesity Medication) Sales and Marketing
12.4.1 Anti-Obesity Drugs (Anti-obesity Medication) Sales Channels
12.4.2 Anti-Obesity Drugs (Anti-obesity Medication) Distributors
12.5 Anti-Obesity Drugs (Anti-obesity Medication) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anti-Obesity Drugs (Anti-obesity Medication) Industry Trends
13.2 Anti-Obesity Drugs (Anti-obesity Medication) Market Drivers
13.3 Anti-Obesity Drugs (Anti-obesity Medication) Market Challenges
13.4 Anti-Obesity Drugs (Anti-obesity Medication) Market Restraints
14 Key Findings in The Global Anti-Obesity Drugs (Anti-obesity Medication) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer